Type 1 Autoimmune Pancreatitis with Type 1 Diabetes

Read full text Summarise with VIRAT
Authors: Marwa M. Elgadi
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: Autoimmune pancreatitis is increasingly recognized yet underdiagnosed. Its presentation overlaps with pancreatic cancer and chronic pancreatitis, making diagnosis difficult without characteristic criteria. Two distinct subtypes exist: type 1 AIP (IgG4-related disease): typically older males, elevated IgG4, multi-organ involvement, high relapse rate, and type 2 AIP: younger age, normal IgG4, limited to pancreas, associated with IBD.IgG4 elevation is a key biomarker but lacks absolute specificity, as mild elevations may occur in malignancies. Therefore, integration of imaging, serology, histology, and steroid response is essential. This case is notable due to: (1) unusually young age for type 1 AIP. (2) Coexistence with type 1 diabetes. (3) Multi-system IgG4-related involvement. Case Description: A 32-year-old Libyan male with type 1 diabetes diagnosed in 1996 (MDI regimen; later transitioned to Medtronic 780 G pump) presented with gradual-onset epigastric pain radiating to the back, nausea, anorexia, Painless jaundice, and a documented episode of hypoglycemia unawareness (RBS: 38 mg/dL). Medical and Surgical History 2020: CBD stone → ERCP, cholecystectomy, appendectomy, 2021: acute pancreatitis and pyelonephritis (amylase: 230 U/L, lipase: 500 U/L), 2022: MRCP showing mild pancreatic duct dilation; IgG4 measured at 2.39 g/L, 2023: episode of prostatitis. No history of alcohol use, smoking, or family history of pancreatic disease. Physical Examination reveals stable vital signs, marked jaundice, Epigastric tenderness without guarding or masses. His Investigations show Total bilirubin: 6.8 mg/dL (direct: 5.1 mg/dL), ALP/GGT: markedly elevated, amylase/lipase: elevated, IgG4: 1,645 mg/dL (significantly elevated). Imaging shows CT abdomen: loss of physiological lobulation with delayed enhancement—classic “sausage-shaped pancreas” appearance, MRCP: diffuse narrowing of main pancreatic duct without focal mass, No radiologic features suggestive of malignancy. The diagnosis of type 1 autoimmune pancreatitis (IgG4-related disease) was established based on: (1) marked serum IgG4 elevation, (2) typical pancreatic imaging findings, (3) extra-pancreatic involvement (biliary, renal, prostate), and (4) strong clinical response to corticosteroids. Coexisting type 1 diabetes of 29-year duration complicated the presentation but did not alter diagnostic certainty. The patient was managed with: prednisolone 5 mg daily (after initial induction), azathioprine 50 mg daily to prevent relapse, pancreatic enzyme replacement (Creon: 25,000 IU) with meals. Clinical improvement occurred rapidly, with resolution of jaundice and pain, and normalization of pancreatic enzymes. Conclusion: This case illustrates a diagnostically challenging presentation of type 1 AIP in a young adult, an age group in which type 2 AIP is typically more common. This case underscores the importance of considering type 1 AIP in young patients with obstructive jaundice and elevated IgG4. Early diagnosis and corticosteroid therapy result in excellent outcomes and prevent unnecessary surgical procedures. Recognition of multi-organ involvement is critical for long-term. Publication History Article published online: 25 March 2026 © 2026. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/) Thieme Medical and Scientific Publishers Pvt. Ltd. A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

Fields of Study & Subjects

IgG4-Related and Inflammatory Diseases Pancreatic and Hepatic Oncology Research Pancreatitis Pathology and Treatment

Publication details

Journal / source
Ibnosina Journal of Medicine and Biomedical Sciences
Volume
18
Publication date
1 March 2026
Language
EN